Aïm F, Klouche S, Frison A, Bauer T, Hardy P
Hôpitaux Universitaires Paris Île-de-France Ouest, AP-HP, 92100 Boulogne-Billancourt, France.
Hôpitaux Universitaires Paris Île-de-France Ouest, AP-HP, 92100 Boulogne-Billancourt, France.
Orthop Traumatol Surg Res. 2017 May;103(3):465-470. doi: 10.1016/j.otsr.2016.12.021. Epub 2017 Mar 4.
Complex regional pain syndrome type I (CRPS-I), previously known as reflex sympathetic dystrophy, is common after conservatively or surgically treated wrist fractures. Several studies support the efficacy of vitamin C in preventing CRPS-I, although the data are somewhat conflicting. The primary objective of this systematic literature review and meta-analysis was to assess the efficacy of vitamin C therapy in preventing CRPS-I after a wrist fracture.
Randomised, placebo-controlled trials of vitamin C to prevent CRPS-I after wrist fractures were sought in the three main databases: PubMed (1980 to December 2015), CENTRAL (Central 2015, number 12), and Embase (1980 to December 2015). Two authors worked independently to select articles. Data from selected articles were collected independently.
Three randomised placebo-controlled trials in a total of 875 patients were included. Treatment was non-operative in 758/890 (85.1%) fractures and operative in 132 (14.9%) fractures. Vitamin C supplementation was started on the day of the injury and continued for 50 days. In the group given 500mg of vitamin C daily, the risk ratio for CRPS-I was 0.54 (95%CI, 0.33-0.91; P=0.02). Thus, the risk of developing CRPS-I was significantly decreased by prophylactic treatment with 500mg of vitamin C per day. The heterogeneity rate was 65% (non-significant).
Daily supplementation with 500mg of vitamin C per day for 50 days decreases the 1-year risk of CRPS-I after wrist fracture.
II, systematic review of level I and II studies.
I型复杂性区域疼痛综合征(CRPS-I),以前称为反射性交感神经营养不良,在手腕骨折经保守治疗或手术治疗后很常见。多项研究支持维生素C预防CRPS-I的有效性,尽管数据存在一定冲突。本系统文献综述和荟萃分析的主要目的是评估维生素C疗法预防手腕骨折后CRPS-I的有效性。
在三个主要数据库中检索维生素C预防手腕骨折后CRPS-I的随机、安慰剂对照试验:PubMed(1980年至2015年12月)、CENTRAL(2015年第12期)和Embase(1980年至2015年12月)。两名作者独立筛选文章。从选定文章中独立收集数据。
共纳入三项随机安慰剂对照试验,涉及875例患者。890例骨折中有758例(85.1%)采用非手术治疗,132例(14.9%)采用手术治疗。受伤当天开始补充维生素C,并持续50天。在每日给予500mg维生素C的组中,CRPS-I的风险比为0.54(95%CI,0.33-0.91;P=0.02)。因此,每天预防性给予500mg维生素C可显著降低发生CRPS-I的风险。异质性率为65%(无统计学意义)。
每天补充500mg维生素C,持续50天,可降低手腕骨折后1年发生CRPS-I的风险。
II,对I级和II级研究的系统评价。